Heikkilä Juha Markus, Bergman Paula, Jantunen Juha, Salimäki Johanna, Kauppi Paula, Pohjanoksa-Mäntylä Marika
Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Biostatistics Unit, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Explor Res Clin Soc Pharm. 2021 Jun 24;3:100040. doi: 10.1016/j.rcsop.2021.100040. eCollection 2021 Sep.
Guided self-management of asthma supported by health care professionals is a well-established approach. For allergy patients, there is less guidelines and evidence for guided self-management than for asthma patients.
The objective of this study was to find out how commonly asthma and allergy patients receive written action plans, how much and from which sources they receive treatment information to support their self-management, and to identify associated factors that may influence the support of guided self-management, and if there are any differences between these patients.
A nationwide survey was conducted in Finnish community pharmacies ( = 785) in September 2016 targeting patients buying prescription medicines for asthma or allergies.
Responses were received from 46% of targeted pharmacies. Around 73% of the asthma patients, 61% of patients at risk of anaphylaxis, and less than 50% of the other allergy patients had received a written action plan. The most common source of treatment information for both patient groups was pharmacists. Allergy patients sought information more from written sources than asthma patients. Older males and patients with lower education received less treatment information. About 10% of both asthma and allergy patients did not report receiving any treatment information.
The majority of asthma patients and allergy patients at risk of anaphylaxis had received a written action plan, while fewer than half of other allergy patients had received a written action plan. For both asthma and allergy patients, community pharmacists are the most common source of treatment information. Allergy patients seek more information from written sources than asthma patients. Pharmacists have a crucial role in the support of self-management for these patients.
由医疗保健专业人员支持的哮喘自我管理指导是一种成熟的方法。对于过敏患者，与哮喘患者相比，自我管理指导的指南和证据较少。
本研究的目的是了解哮喘和过敏患者接受书面行动计划的频率、他们获得支持自我管理的治疗信息的数量和来源，确定可能影响自我管理指导支持的相关因素，以及这些患者之间是否存在差异。
2016年9月在芬兰社区药房（共785家）进行了一项全国性调查，目标是购买哮喘或过敏处方药的患者。
46%的目标药房回复了调查。约73%的哮喘患者、61%的有过敏反应风险的患者以及不到50%的其他过敏患者收到了书面行动计划。两个患者群体最常见的治疗信息来源都是药剂师。过敏患者从书面来源获取信息的频率高于哮喘患者。老年男性和教育程度较低的患者获得的治疗信息较少。约10%的哮喘和过敏患者表示未收到任何治疗信息。
大多数哮喘患者和有过敏反应风险的过敏患者收到了书面行动计划，而其他过敏患者中不到一半收到了书面行动计划。对于哮喘和过敏患者来说，社区药剂师是最常见的治疗信息来源。过敏患者从书面来源获取的信息比哮喘患者更多。药剂师在支持这些患者的自我管理方面起着至关重要的作用。
